FDA to inspect ID Biomedical plant in bid to import surplus flu vaccine

TORONTO (CP) - Officials of the U.S. Food and Drug Administration will inspect the Ste-Foy, Que., flu vaccine production plant of ID Biomedical next week in a bid to approve the company's surplus vaccine for importation to the United States....More